US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: A 46.51% Potential Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, particularly given its robust revenue growth and the promising outlook from analysts...

Chemed Corp (CHE) Stock Analysis: Healthcare Service Leader Eyes 16.85% Potential Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is drawing investor attention with its robust service offerings and a notable potential upside of 16.85%. Headquartered in Cincinnati,..

Glaukos Corporation (GKOS) Stock Analysis: Strong Buy Ratings and a Potential 12% Upside for This Medical Device Innovator

Investors eyeing the healthcare sector might want to take a closer look at Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic pharmaceuticals and medical technology. With a market capitalization of..

Mettler-Toledo International (MTD): Investor Outlook on a Healthcare Giant with 8.99% Potential Upside

Mettler-Toledo International Inc. (NYSE: MTD), a powerhouse in precision instruments within the healthcare sector, is capturing the attention of investors with its robust market position and promising prospects. Headquartered in..

Revolution Medicines (RVMD) Stock Analysis: Exploring a 19.75% Upside in the Precision Oncology Space

Revolution Medicines, Inc. (NASDAQ: RVMD) has been making waves in the biotechnology sector with its cutting-edge research in precision oncology. As a clinical-stage company focused on developing novel therapies for..

Repligen Corporation (RGEN) Stock Analysis: Growth Momentum and a 40% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in bioprocessing technologies and systems that cater to the life sciences industry. With a market capitalization of $7.64..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 26% Upside Potential with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with a significant upside potential and robust..

Grifols, S.A. (GRFS)

⚠️ No article content returned.

..

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 48.56% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) is carving a niche in the healthcare technology sector, with its innovative solutions that combine molecular testing with data analytics. Despite recent market challenges, the..

Elevance Health, Inc. (ELV) Stock Analysis: Uncovering a 13.10% Upside Potential in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure to the rapidly evolving U.S. healthcare market. With a..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 7.3% Upside Potential Amid Robust Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP), an established leader in clinical research-based drug and medical device development, has recently caught the attention of investors and analysts alike. With a robust market..

United Therapeutics Corporation (UTHR) Stock Analysis: Potential Upside of 13.77% Amid Robust Pipeline and Strategic Collaborations

United Therapeutics Corporation (NASDAQ: UTHR), a prominent player in the healthcare sector, is making waves with its strong focus on addressing unmet medical needs in the treatment of chronic and..

Cardinal Health, Inc. (CAH) Stock Analysis: Steady Growth and a 10% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is making waves with its compelling financial performance and promising growth trajectory. With a market capitalization of $52.81..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 20.63% Potential Upside Amidst Challenging Metrics

Avantor, Inc. (NYSE: AVTR), a prominent player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry, finds itself at a critical juncture. With a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Player with Robust Revenue Growth and Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $12.24 billion,..

Quest Diagnostics (DGX) Stock Analysis: Strong Revenue Growth and a Promising 7.39% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.52 billion, Quest Diagnostics..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 38.69% Potential Upside in the Biotech Sector

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology firm headquartered in San Rafael, California, is making significant strides in the healthcare sector by pioneering therapies for rare and life-threatening diseases...

Boston Scientific Corporation (BSX) Stock Analysis: Evaluating a 40% Potential Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a titan in the medical device industry, presents an enticing opportunity for investors with a robust market capitalization of $110.6 billion. As a leader in..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating an 11.18% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector, is garnering significant investor attention. With a market capitalization of $39.85 billion, Teva is a key player in the..

Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and diverse product offerings in the medical instruments..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds